Robert Hogg

Dikutip oleh

	Semua	Sejak 2020
Kutipan	64381	16628
indeks-h	116	53
indeks-i10	584	302

4100

2050

1025

3075

1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025161 277 449 475 607 877 1166 1379 1563 1601 1930 2007 2625 2836 3205 3280 3319 3558 3495 4004 3924 3697 3719 3770 3480 2853 2503 293

Akses publik

Lihat semua

329 artikel

53 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

Dr. Julio Montaner, OC, OBC, MD, FR...Director of the BC-CfE; Director of IDC and Physician Program Director for HIV/AIDS PHCEmail yang diverifikasi di bccfe.ca
Martin T. SchechterProfessor of Population and Public Health, University of British ColumbiaEmail yang diverifikasi di ubc.ca
Viviane Dias LimaBC Centre for Excellence in HIV/AIDS & University of British ColumbiaEmail yang diverifikasi di bccfe.ca
Keith Chanprecision heorEmail yang diverifikasi di precisionvh.com
David MooreUniversity of British ColumbiaEmail yang diverifikasi di bccfe.ca
Nathan LachowskyUniversity of VictoriaEmail yang diverifikasi di uvic.ca
Mark TyndallProfessor, School of Population and Public Health, UBCEmail yang diverifikasi di ubc.ca
Steffanie A StrathdeeUniversity of California San DiegoEmail yang diverifikasi di ucsd.edu
Kate SaltersSimon Fraser UniversityEmail yang diverifikasi di sfu.ca
Kiffer G. CardFaculty of Health Sciences, Simon Fraser UniversityEmail yang diverifikasi di sfu.ca
Mona LoutfyWomen's College HospitalEmail yang diverifikasi di wchospital.ca
Arn (Arnold) James SchilderBC Centre for Excellence in HIV/AIDS, Providence Health Care Society,Email yang diverifikasi di cfenet.ubc.ca
David BangsbergProvost and Dean College of Health Sciences, VinUniversityEmail yang diverifikasi di vinuni.edu.vn
Janet RaboudUniversity Health NetworkEmail yang diverifikasi di raboud.net
Jonathan SterneProfessor of Medical Statistics and Epidemiology, University of BristolEmail yang diverifikasi di bristol.ac.uk
Anita PalepuProfessor of Medicine, University of British ColumbiaEmail yang diverifikasi di hivnet.ubc.ca
Hasina SamjiBC Centre for Disease ControlEmail yang diverifikasi di bccdc.ca
Ashleigh J RichDuke University School of NursingEmail yang diverifikasi di duke.edu
Zabrina BrummeAssociate Professor, Faculty of Health Sciences, Simon Fraser UniversityEmail yang diverifikasi di sfu.ca
Cari MillerFaculty of Health Sciences, Simon Fraser UniversityEmail yang diverifikasi di sfu.ca

Ikuti

Robert Hogg

Faculty of Health Sciences, Simon Fraser University

Email yang diverifikasi di sfu.ca - Beranda

Demography Population Health HIV


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global … H Wang, M Naghavi, C Allen, RM Barber, ZA Bhutta, A Carter, DC Casey, ... The lancet 388 (10053), 1459-1544, 2016	5722	2016
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies M Egger, M May, G Chêne, AN Phillips, B Ledergerber, F Dabis, ... The Lancet 360 (9327), 119-129, 2002	2138	2002
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. TCC Antiretroviral Lancet 372 (9635), 293, 2008	2074	2008
Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada H Samji, A Cescon, RS Hogg, SP Modur, KN Althoff, K Buchacz, ... PloS one 8 (12), e81355, 2013	1711	2013
Effect of early versus deferred antiretroviral therapy for HIV on survival MM Kitahata, SJ Gange, AG Abraham, B Merriman, MS Saag, AC Justice, ... New England Journal of Medicine 360 (18), 1815-1826, 2009	1635	2009
Improved survival among HIV-infected individuals following initiation of antiretroviral therapy RS Hogg, KV Heath, B Yip, KJP Craib, MV O'shaughnessy, MT Schechter, ... Jama 279 (6), 450-454, 1998	1125	1998
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies When To Start Consortium The Lancet 373 (9672), 1352-1363, 2009	1036	2009
Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy RS Hogg, B Yip, KJ Chan, E Wood, KJP Craib, MV O'Shaughnessy, ... Jama 286 (20), 2568-2577, 2001	1026	2001
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study JSG Montaner, VD Lima, R Barrios, B Yip, E Wood, T Kerr, K Shannon, ... The Lancet 376 (9740), 532-539, 2010	974	2010
Causes of death in HIV-1–infected patients treated with antiretroviral therapy, 1996–2006: Collaborative analysis of 13 HIV cohort studies ATC Collaboration Clinical infectious diseases: an official publication of the Infectious …, 2010	769	2010
Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada W Zhang, N O’Brien, JI Forrest, KA Salters, TL Patterson, JSG Montaner, ... PloS one 7 (7), e40793, 2012	755	2012
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic JSG Montaner, R Hogg, E Wood, T Kerr, M Tyndall, AR Levy, PR Harrigan The Lancet 368 (9534), 531-536, 2006	707	2006
Barriers to use of free antiretroviral therapy in injection drug users SA Strathdee, A Palepu, PGA Cornelisse, B Yip, MV O'Shaughnessy, ... Jama 280 (6), 547-549, 1998	603	1998
Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy PR Harrigan, RS Hogg, WWY Dong, B Yip, B Wynhoven, J Woodward, ... The Journal of infectious diseases 191 (3), 339-347, 2005	569	2005
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up RS Hogg, K Heath, D Bangsberg, B Yip, N Press, MV O'Shaughnessy, ... Aids 16 (7), 1051-1058, 2002	558	2002
Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda EJ Mills, C Bakanda, J Birungi, K Chan, N Ford, CL Cooper, JB Nachega, ... Annals of internal medicine 155 (4), 209-216, 2011	546	2011
Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350× 109 cells/L E Wood, RS Hogg, B Yip, PR Harrigan, MV O'Shaughnessy, ... Annals of internal medicine 139 (10), 810-816, 2003	490	2003
Decline in deaths from AIDS due to new antiretrovirals RS Hogg, MV O'Shaughnessy, N Gataric, B Yip, K Craib, MT Schechter, ... The Lancet 349 (9061), 1294, 1997	467	1997
Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV Treatment as Prevention” experience in a … JSG Montaner, VD Lima, PR Harrigan, L Lourenço, B Yip, B Nosyk, ... PloS one 9 (2), e87872, 2014	457	2014
Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens RS Hogg, B Yip, C Kully, KJP Craib, MV O'Shaughnessy, MT Schechter, ... Cmaj 160 (5), 659-665, 1999	450	1999

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama